• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

OGT2115 Inhibitor – OGT 2115

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5755300

OGT 2115 is an effective and cell-permeable heparanase inhibitor (IC50: 0.4uM). OGT 2115 also suppresses heparan sulfate degradation activity. OGT 2115 has anti-angiogenic properties (IC50: 1uM). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
OGT 2115 (OGT2115), Inhibitor
Full Product Name
OGT 2115
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
495.3
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C24H16BrFN2O4
SMILES
O=C(O)CC1=CC=C(OC(C2=CC=C(NC(/C=C/C3=CC=C(Br)C=C3)=O)C(F)=C2)=N4)C4=C1
CAS Number
853929-59-6
Target & IC50
Heparanase: ic50 0.4uM
In Vitro
OGT 2115 displays a plasma concentration of ~10x the heparanase IC50 following oral dosing at 20mg/kg when administered to mice[1].

Structure of OGT2115, inhibitor

OGT2115 Inhibitor – Cat# MBS5755300

Product References and Citations for OGT2115, inhibitor

Courtney SM, et al. Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor. Bioorg Med Chem Lett. 2005 May 2;15(9):2295-9.
Courtney SM, et al. Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor. Bioorg Med Chem Lett. 2005 May 2;15(9):2295-9.
Li Y, et al. Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase. Int J Mol Med. 2013 May;31(5):1234-42.
Li Y, et al. Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase. Int J Mol Med. 2013 May;31(5):1234-42.

Other Notes

Small volumes of OGT2115, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for OGT2115 purchase

MBS5755300 is an inhibitor targeting OGT2115. Also known as OGT 2115.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000